Mirae Asset Global Investments Co., Ltd. Embecta Corp. Transaction History

Mirae Asset Global Investments Co., Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$12.35 - $19.33 $69,826 - $109,291	-5,654 Reduced 18.44%	25,000 $331,000
Q4 2023 Jan 24, 2024	BUY	$12.87 - $19.09 $1,158 - $1,718	90 Added 0.29%	30,654 $580,000
Q3 2023 Oct 26, 2023	BUY	$15.0 - $22.17 $12,510 - $18,489	834 Added 2.81%	30,564 $459,000
Q2 2023 Aug 10, 2023	BUY	$21.6 - $30.69 $102,168 - $145,163	4,730 Added 18.92%	29,730 $642,000
Q4 2022 Feb 09, 2023	BUY	$25.29 - $35.48 $16,210 - $22,742	641 Added 2.63%	25,000 $632,000
Q3 2022 Nov 10, 2022	SELL	$24.0 - $33.42 $2.33 Million - $3.25 Million	-97,240 Reduced 79.97%	24,359 $701,000
Q2 2022 Jul 26, 2022	BUY	$24.78 - $33.36 $3.01 Million - $4.06 Million	121,599 New	121,599 $3.08 Million

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.